ArticleBMC pulmonary medicine2025
Survival analysis of patients with pneumoconiosis followed in occupational medicine clinics: 10 years experience.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Health inequities in the comorbid association between pneumoconiosis and chronic obstructive pulmonary disease: a nationwide study of age-related heterogeneity.Respiratory research · 2026Article
- Incidence analysis of occupational respiratory diseases in Türkiye: a cross-sectional legal registry-based study from 2013 to 2023.BMC public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPneumoconiosis is still the most common occupational disease worldwide. The aim of the study was to evaluate the risk factors affecting survival in patients with pneumoconiosis who were followed up in occupational medicine clinics.
methodsThis retrospective descriptive study included all pneumoconiosis patients followed up in occupational medicine clinics between 2013 and 2023. The patients' death records were accessed through the national death notification system.
resultsA total of 539 patients were included in the study. During the clinical follow-up, 14 (2.56%) patients had died. The mean overall survival time was 224 ± 13 months. In multiple analyses, silica exposure (p = 0.029) and lung cancer development (p = 0.002) were associated with survival. There was no difference between stages 0 and 1, stage 2 and stage 3 in terms of age at diagnosis, type of disease and duration of dust exposure (respectively p = 0.109, p = 0.852).
conclusionsThis study showed that exposure to silica as a dust type and the development of lung cancer increased mortality in patients with pneumoconiosis. Determining the factors that may be associated with mortality in patients with pneumoconiosis is important in patient follow-up and in developing preventive measures and policies. It is crucial that the establishment of lung cancer screening programs contribute to life expectancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.